CTOs on the Move

RBC Life Sciences

www.rbclifesciences.com

 
RBC Life Sciences, Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. RBC Life Sciences, Inc is based in Irving, TX. You can find more information on RBC Life Sciences, Inc at www.rbclifesciences.com
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

SciTec

SciTec is a company that provides cutting edge advancements for defense, security, and civil affairs. Their team is committed to delivering advanced sensor systems, data processing algorithms, and testing equipment for defense, national security, and c...

Windrix Transcription

Windrix Transcription is a Pleasant Hill, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tucson Orthopaedic Institute

Tucson Orthopaedic Institute is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Tucson, AZ. To find more information about Tucson Orthopaedic Institute, please visit www.tucsonortho.com

Sunset Manor

Sunset Manor is a Geneva, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PolyNovo Limited

At PolyNovo we are driven by improving the outcomes of patients through development and provision of the best surgical solutions possible. PolyNovo develops innovative medical devices utilizing the patented bioabsorbable polymer technology Novosorb®. NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products via established pathways. NovoSorb BTM (Biodegradable Temporizing Matrix) is the first product commercialized by PolyNovo. In 2015, following the FDA 510(K) clearance of BTM, PolyNovo was awarded an $11 million contract and a further $25 million in funding from the US-based Biomedical Advanced Research and Development Authority (BARDA) to complete a trial with BTM for full thickness burns. We have expanded our manufacturing facility and headquarters in Melbourne, Australia, establishing high quality processes, enabling product innovation and preparing for growth.